efonidipine has been researched along with tipranavir in 1 studies
| Studies (efonidipine) | Trials (efonidipine) | Recent Studies (post-2010) (efonidipine) | Studies (tipranavir) | Trials (tipranavir) | Recent Studies (post-2010) (tipranavir) |
|---|---|---|---|---|---|
| 129 | 18 | 30 | 289 | 42 | 47 |
| Protein | Taxonomy | efonidipine (IC50) | tipranavir (IC50) |
|---|---|---|---|
| Protease | Human immunodeficiency virus 1 | 0.03 | |
| CAAX prenyl protease 1 homolog | Mus musculus (house mouse) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KS; Cabeza de Vaca, I; Deshmukh, M; Ghahremanpour, MM; Ippolito, JA; Jorgensen, WL; Liosi, ME; Tirado-Rives, J; Zhang, CH | 1 |
1 other study(ies) available for efonidipine and tipranavir
| Article | Year |
|---|---|
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2.
Topics: | 2020 |